Results 161 to 170 of about 77,065 (293)

Radioimmunoassay for the Antigenic Determinants of Cholera Toxin and Its Components [PDF]

open access: bronze, 1977
Kelly E. Hejtmancik   +3 more
openalex   +1 more source

Rice‐derived SARS‐CoV‐2 glycoprotein S1 subunit vaccine elicits humoral and cellular immune responses

open access: yesPlant Biotechnology Journal, Volume 23, Issue 7, Page 2570-2582, July 2025.
Summary Since 2019, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus causing COVID‐19, has been spreading and mutating globally despite the expedited approval of many commercial vaccines. Therefore, developing safe, effective and affordable vaccines remains essential to meet the global demand, particularly in developing countries.
Li Song   +14 more
wiley   +1 more source

Characterization and utility of two monoclonal antibodies to cholera toxin B subunit. [PDF]

open access: yesSci Rep, 2023
Verjan Garcia N   +3 more
europepmc   +1 more source

Anti-Cholera toxin activity of selected polyphenols from Careya arborea, Punica granatum, and Psidium guajava. [PDF]

open access: yesFront Cell Infect Microbiol, 2023
Charla R   +8 more
europepmc   +1 more source

Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques. [PDF]

open access: yesFront Immunol, 2023
Rahman MA   +17 more
europepmc   +1 more source

Endocytosis of cholera toxin into neuronal GERL.

open access: green, 1978
K. C. Joseph   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy